On Tuesday, Great Basin Scientific Inc (NASDAQ:GBS
Post# of 129
Posted On: 11/25/2015 9:05:46 AM
On Tuesday, Great Basin Scientific Inc (NASDAQ:GBSN)’s shares inclined 120.00% to $0.121.
GBSN is currently valued at $23.62 million. The company has 190.68 million shares outstanding and 4.10% shares of the company were owned by institutional investors. The company has -12.84 value in price to sale ratio. The company exchanged hands with 95.40 million shares as compared to its average daily volume of 9.85 million shares.
The mean estimate for the short term price target for Great Basin Scientific Inc (NASDAQ:GBSN) stands at $9.69 according to 2 Analysts. The higher price target estimate for the stock has been calculated at $10.00 while the lower price target estimate is at $9.38.
Analysts mean recommendation for the stock is 2.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious disease. The Company has a commercially available test, a diagnostic test for clostridium difficile (C. diff), which received clearance from the Food and Drug Administration (FDA).
GBSN is currently valued at $23.62 million. The company has 190.68 million shares outstanding and 4.10% shares of the company were owned by institutional investors. The company has -12.84 value in price to sale ratio. The company exchanged hands with 95.40 million shares as compared to its average daily volume of 9.85 million shares.
The mean estimate for the short term price target for Great Basin Scientific Inc (NASDAQ:GBSN) stands at $9.69 according to 2 Analysts. The higher price target estimate for the stock has been calculated at $10.00 while the lower price target estimate is at $9.38.
Analysts mean recommendation for the stock is 2.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious disease. The Company has a commercially available test, a diagnostic test for clostridium difficile (C. diff), which received clearance from the Food and Drug Administration (FDA).
(0)
(0)Great Basin Scientific, Inc. (GBSNQ) Stock Research Links
Here We Go!!!!